Financial calendar 2015/16


 

Company announcement no.15/2015

 

2015

21 October              Annual Report 2014/15

26 November           Annual General Meeting

Please note that subjects and proposals that shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Wednesday 14 October at 16.00 CET.

 

 

2016

14 January              Interim Report (Q1 2015/16)

7 April                    Interim Report (Q2 2015/16)

5 July                     Interim Report (Q3 2015/16)

26 October             Annual Report 2015/16

29 November          Annual General Meeting

Please note that subjects and proposals that shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Monday, 17 October at 16.00 CET.

 

For further information, please contact:

Anders Mohr Christensen, Senior Director, Investor Relations
Tel: +45 4574 7618

 

About Chr. Hansen

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen. For further information, please visit www.chr-hansen.com.


Attachments

No 15 2015 US.pdf